Drugs that contain Memantine Hydrochloride

1. Drug name - NAMENDA XR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8039009 ALLERGAN Modified release formulations of memantine oral dosage forms Mar, 2029

(6 years from now)

US8039009

(Pediatric)

ALLERGAN Modified release formulations of memantine oral dosage forms Sep, 2029

(6 years from now)

Treatment: Treatment of moderate to severe dementia of the alzheimer's type

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
7MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
14MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
21MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
28MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.